These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 9171275

  • 1. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M, Stanek B, Frey B, Berger R, Rödler S, Siegel A, Hartter E, Schuller M, Ogris E, Pacher R.
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [Abstract] [Full Text] [Related]

  • 2. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A, Stanek B, Kubecova L, Vitovec J, Spinar J, Yilmaz N, Kos T, Hartter E, Frey B, Pacher R.
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [Abstract] [Full Text] [Related]

  • 3. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
    Pacher R, Stanek B, Hülsmann M, Bojic A, Berger R, Frey B, Siegel A, Kos T, Ogris E, Grimm M, Laufer G.
    J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
    [Abstract] [Full Text] [Related]

  • 5. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M, Hülsmann M, Berger R, Rödler S, Frey B, Stanek B, Pacher R.
    Wien Klin Wochenschr; 1998 Jul 31; 110(13-14):473-8. PubMed ID: 9746960
    [Abstract] [Full Text] [Related]

  • 6. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Jul 31; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
    Serra W, Musiari L, Ardissino D, Gherli T, Montanari A.
    Int J Cardiol; 2011 Jan 07; 146(1):e10-5. PubMed ID: 19176262
    [Abstract] [Full Text] [Related]

  • 11. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T, Pacher R, Wimmer A, Bojic A, Hülsmann M, Frey B, Mayer G, Yilmaz N, Skvarilova L, Spinar J, Vitovec J, Toman J, Woloszcuk W, Stanek B.
    Wien Klin Wochenschr; 1998 Feb 13; 110(3):89-95. PubMed ID: 9553203
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K, Gottlieb S, Fleck E, Kostis J, Levine B, DeKock M, LeJemtel T.
    J Hypertens Suppl; 1994 Jul 13; 12(2):S31-5. PubMed ID: 7965263
    [Abstract] [Full Text] [Related]

  • 13. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T, Ishikita T, Matsuura H, Saji T.
    J Cardiol; 2001 Nov 13; 38(5):263-71. PubMed ID: 11729726
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T, Morimoto Y, Kakuta Y, Konishi T, Kodera T, Kanamaru M, Takezawa H.
    Arzneimittelforschung; 1986 Dec 13; 36(12):1829-34. PubMed ID: 3551968
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
    Sasaki T, Kubo T, Komamura K, Nishikimi T.
    J Cardiol; 1999 Jun 13; 33(6):317-25. PubMed ID: 10396705
    [Abstract] [Full Text] [Related]

  • 16. Early and medium term results of tailored therapy for heart failure.
    Martins S, Soares RM, do Rosário L, Quininha J, Antunes AM.
    Rev Port Cardiol; 2001 Mar 13; 20(3):261-82. PubMed ID: 11417309
    [Abstract] [Full Text] [Related]

  • 17. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P, Ramaprasad S.
    Pharmacotherapy; 1997 Mar 13; 17(2):371-4. PubMed ID: 9085331
    [Abstract] [Full Text] [Related]

  • 18. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M, Levine TB, Cohn JN.
    Circulation; 1986 Mar 13; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS, Gottlieb SS, Singh BN, Ramanathan KB, Ogilby JD, Ellenbogen KA.
    J Am Coll Cardiol; 1995 Dec 13; 26(7):1679-84. PubMed ID: 7594103
    [Abstract] [Full Text] [Related]

  • 20. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
    Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I, Kettner J, Kautzner J.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):595-600. PubMed ID: 19660688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.